系统性红斑狼疮患者需住院感染的预测因素:至事件发生时间分析
在单中心前瞻性随访的346例系统性红斑狼疮(SLE)患者中,平均随访6.6年(标准差3.7),观察到86次严重感染,发生率为每100人年3.8次。既往严重感染史是最强的严重感染预测因素,环磷酰胺、较高的SLE损伤指数(SDI)评分和较高疾病活动度与首次严重感染风险增加相关,淋巴细胞减少也是 modest 但统计学显著的预测因素。
要点
- 既往严重感染史是SLE患者严重感染的最强预测因素。
- 环磷酰胺、较高SDI评分和较高疾病活动度与首次严重感染风险增加独立相关。
- 淋巴细胞减少是严重感染的 modest 但统计学显著预测因素。
核心结论
- 既往严重感染史是本SLE队列中严重感染的最强预测因素。
- 本研究还提示,损伤累积、疾病活动度和免疫抑制剂选择等临床因素可各自独立预测严重感染风险,尤其是首次发作。
研究设计与样本
- 在单中心前瞻性随访队列中识别SLE患者的严重感染。
- 使用Cox及相关回归模型分析严重感染与疾病相关变量和药物使用的关联。
- 346例患者平均随访6.6年(标准差3.7)。
主要发现
- 观察到86次严重感染,发生率为每100人年3.8次。
- 发生严重感染的患者基线SDI和Charlson共病指数(CCI)更高,更可能有高疾病活动状态(HDAS)、多个临床领域疾病活动度更高、 flare率更高、时间调整的泼尼松龙剂量暴露更高,以及在狼疮低疾病活动状态(LLDAS)中时间更少。
- 接受环磷酰胺、利妥昔单抗和霉酚酸酯的患者更可能发生严重感染。
- 多变量调整Cox回归分析后,环磷酰胺、较高SDI评分和较高疾病活动度与首次严重感染风险增加相关。
- 既往严重感染史带来最高风险,淋巴细胞减少也是 modest 但统计学显著的严重感染预测因素。
关键数值与推荐
- 严重感染发生率:每100人年3.8次。
- 多变量调整Cox回归中,环磷酰胺、较高SDI评分和较高疾病活动度与首次严重感染风险增加相关;既往严重感染史风险最高;淋巴细胞减少为 modest 但统计学显著预测因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the predictors of serious infection in patients with systemic lupus erythematosus (SLE). METHODS: Serious infections were identified in SLE patients in a prospectively-followed single centre cohort. Associations of serious infection with disease-related variables and medication use were analysed using Cox and related regression models. RESULTS: 346 patients were followed for a mean (SD) of 6.6 (3.7) years. 86 episodes of serious infection were observed, with an incidence rate of 3.8 episodes per 100 person-years. Patients who had serious infection had higher baseline SLE Damage Index (SDI) and Charlston Comorbidity Index (CCI); they were also more likely to have high disease activity status (HDAS), and higher disease activity in multiple clinical domains, higher flare rates, higher time-adjusted prednisolone dose exposure, and less time in lupus low disease activity state (LLDAS). Patients who have received cyclophosphamide, rituximab and mycophenolate were more likely to have experienced serious infection. After multivariable adjustment in Cox regression analysis, cyclophosphamide, higher SDI score, and higher disease activity were associated with an increased hazard of first serious infection. History of previous serious infection conferred the highest risk. Lymphopenia was also a modest but statistically significant predictor of serious infection. CONCLUSION: History of previous serious infection was the strongest predictor of serious infection in our SLE cohort. This study also suggests that clinical factors such as damage accrual, disease activity, and choice of immunosuppressant, can each have an independent risk in predicting serious infection particularly the first episode.
引用
- Ko T, Koelmeyer R, Li N, et al. Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis. Semin Arthritis Rheum. 2022. PMID: 36155969. doi:10.1016/j.semarthrit.2022.152099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。